Posaconazole Intravenous (Iv) Solution 300 mg/100 mL Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV) solution
Available Strengths: 300 mg/100 mL
Reference Brands: Noxafil(US & EU)
Category: Anti-fungal
Posaconazole IV inhibits fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis and fungal cell membrane formation. It provides broad-spectrum antifungal activity, rapid systemic absorption, and excellent tissue penetration. Benefits include effective treatment of invasive fungal infections, reliable intravenous delivery, and high bioavailability, crucial for managing severe fungal diseases.
Product Description:
Posaconazole IV is approved in the EU and US for treating invasive fungal infections. In the EU, MSD’s Noxafil IV is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data, biosimilarity assessments, and ongoing pharmacovigilance. Both regions require detailed regulatory dossiers for initial approval and continued safety monitoring. For expert assistance with pharmaceutical dossiers, regulatory submissions, and compliance, visit PharmaTradz. We support efficient market access for posaconazole IV formulations, ensuring adherence to European and American standards for safe, effective antifungal therapy.
Posaconazole Intravenous (Iv) Solution — third party manufacturing & bulk supply
Posaconazole Intravenous (Iv) Solution 300 mg/100 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Posaconazole Intravenous (Iv) Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Posaconazole Intravenous (Iv) Solution →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Posaconazole is used to prevent and treat serious fungal infections, particularly in immunocompromised patients such as those with hematologic malignancies or stem-cell transplants. It is effective against invasive aspergillosis, mucormycosis, and infections caused by Candida species. It is commonly used when patients cannot tolerate or do not respond to other antifungal therapies.
Posaconazole contains the active triazole antifungal compound posaconazole. The formulation includes pharmaceutical excipients that enhance absorption and maintain stability, depending on the dosage form used.
The main trade name for posaconazole is Noxafil, recognized in the USA, EU, UK, and many international markets.
Noxafil (posaconazole) is manufactured by Merck & Co. Generic versions may also be produced by other GMP-certified pharmaceutical companies in different regions.
The generic name is posaconazole.
The primary brand name is Noxafil.
Posaconazole is manufactured in Merck’s regulated facilities located in the USA and Europe, along with various GMP-approved global manufacturers producing generic posaconazole for international distribution.
Related Products
Tioconazole
Strength:
6.5%, 300 mg, 1%
Form: Vaginal Capsule / Vaginal Cream/ topical cream
Reference Brands: Vagistat-1 (USA), Trosyd (EU/LATAM)
View Details
Terconazole
Strength:
0.4%, 0.8%, 80 mg, 120 mg
Form: Cream / Vaginal suppository
Reference Brands: Terazol (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
